Michael P. Stern

Active 1967–2025

105
Papers
23,246
Citations
85
h-index
105
i10-index

Citations

Citations per year for Michael P. Stern1968: 5 citations1969: 4 citations1970: 2 citations1971: 3 citations1972: 5 citations1973: 6 citations1974: 9 citations1975: 8 citations1976: 9 citations1977: 12 citations1978: 12 citations1979: 26 citations1980: 22 citations1981: 11 citations1982: 27 citations1983: 15 citations1984: 25 citations1985: 12 citations1986: 33 citations1987: 22 citations1988: 46 citations1989: 43 citations1990: 69 citations1991: 69 citations1992: 42 citations1993: 41 citations1994: 51 citations1995: 54 citations1996: 110 citations1997: 130 citations1998: 129 citations1999: 139 citations2000: 206 citations2001: 209 citations2002: 235 citations2003: 272 citations2004: 277 citations2005: 325 citations2006: 335 citations2007: 335 citations2008: 282 citations2009: 207 citations2010: 210 citations2011: 156 citations2012: 141 citations2013: 136 citations2014: 106 citations2015: 121 citations2016: 82 citations2017: 77 citations2018: 69 citations2019: 247 citations2020: 231 citations2021: 195 citations2022: 126 citations2023: 64 citations2024: 127 citations2025: 54 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,625 citing papers, 37.8% of this breakdownUnited Kingdom: 530 citing papers, 7.6% of this breakdownItaly: 288 citing papers, 4.1% of this breakdownChina: 268 citing papers, 3.9% of this breakdownCanada: 252 citing papers, 3.6% of this breakdownAustralia: 226 citing papers, 3.3% of this breakdownGermany: 221 citing papers, 3.2% of this breakdownSweden: 180 citing papers, 2.6% of this breakdownNetherlands: 169 citing papers, 2.4% of this breakdownJapan: 160 citing papers, 2.3% of this breakdownFrance: 159 citing papers, 2.3% of this breakdownSpain: 152 citing papers, 2.2% of this breakdown
0%37.8%Other 24.7%

Fields

  • Medicine71.7%
  • Biochemistry, Genetics and Molecular Biology14.4%
  • Neuroscience3.8%
  • Nursing2.7%
  • Health Professions1.8%
  • Psychology1.3%
  • Other4.3%

Topics

  • Diabetes, Cardiovascular Risks, and Lipoproteins10%
  • Adipokines, Inflammation, and Metabolic Diseases3.9%
  • Adipose Tissue and Metabolism2.5%
  • Metabolism, Diabetes, and Cancer2.4%
  • Rheumatoid Arthritis Research and Therapies2.2%
  • Liver Disease Diagnosis and Treatment2.1%
  • Other76.9%

Coauthors

All papers

Open in search
  1. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

    Authors: , , , , - Arthritis & Rheumatism 2001 cited by 1,349

  2. Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease

    Authors: , , , - Diabetes Care 2002 cited by 639

  3. Fueling the Obesity Epidemic? Artificially Sweetened Beverage Use and Long‐term Weight Gain

    Authors: , , , , , - Obesity 2008 cited by 466

  4. Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements

    Authors: , , , , , - Diabetes 2005 cited by 390

  5. What Is the Best Predictor of Future Type 2 Diabetes?

    Authors: , , , - Diabetes Care 2007 cited by 356

  6. Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?

    Authors: , , , , - Diabetes Care 2004 cited by 738

  7. Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?

    Authors: , , - Annals of Internal Medicine 2002 cited by 512

  8. The Metabolic Syndrome as Predictor of Type 2 Diabetes

    Authors: , , , , - Diabetes Care 2003 cited by 800

  9. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Donna Kritz‐Silverstein, Mary Lou Carrion-Petersen, Carmela Cavero, Helmut G. Schrott, Susan R. Johnson, D Feddersen, Denise L. Krutzfeldt, J Bénda, Carl J. Pauerstein, José F. Trabal, Robert S. Schenken, Michael P. Stern, Mercedes Rodriguez-Sifuentes, Carann Easton, H. Bradley Wells, Mark A. Espeland, George Howard, Robert Byington, Claudine Legault, Sally A. Shumaker, Patricia E. Hogan, Don Hire, Carol H. Wasilauskas, Margaret K. James, Kathy Lane, Tim Terrell, Stephanie Reece, J. Thomas Pierce, Mary Snow, Susan E. Anthony, Irma Mebane-Sims, Paula T. Einhorn, Sally Hunsberger, Myron A. Waclawiw, K Lippel, Diane L. Lucas, Joel Verter, Sherry Avery Jackson, Joseph Kelaghan, Jeffrey A. Perlman, Pam Wolf, Joan McGowan, S Gordon, Stephen P. Heyse, Judith Fradkin, Sherry Sherman, Lot B. Page, Ann W. Sorenson, Barbara S. Hulka, Baruch A. Brody, Ronald T. Burkman, Robert P. Heaney, Ronald M. Krauss, Harold G. Roberts, Janet Wittes, Lawrence B. Riggs, Richard B. Moss, John J. Albers, Santica M. Marcovina, S Edwin Fineberg, Russell P. Tracy, María Merino, Robert E. Scully, Virginia A. LiVolsi, Gerald Kessler - JAMA 1995 cited by 605

  10. Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study

    Authors: , , , - Diabetes Care 1998 cited by 478

  11. Insulin-Resistant Prediabetic Subjects Have More Atherogenic Risk Factors Than Insulin-Sensitive Prediabetic Subjects

    Authors: , , , , - Circulation 2000 cited by 456

  12. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

    Authors: , , , , , , , , , , , - The Lancet 2010 cited by 286

  13. Prediction of Type 2 Diabetes Using Simple Measures of Insulin Resistance

    Authors: , , , , , , - Diabetes 2003 cited by 202

  14. The Homeostasis Model in the San Antonio Heart Study

    Authors: , , - Diabetes Care 1997 cited by 793

  15. Waist Circumference as the Best Predictor of Noninsulin Dependent Diabetes Mellitus (NIDDM) Compared to Body Mass Index, Waist/hip Ratio and Other Anthropometric Measurements in Mexican Americans—A 7‐Year Prospective Study

    Authors: , , , - Obesity Research 1997 cited by 482

  16. Genetic and Environmental Contributions to Cardiovascular Risk Factors in Mexican Americans

    Authors: , , , , , , , , , , , , - Circulation 1996 cited by 376

  17. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects

    Authors: , , , , , - Arthritis & Rheumatism 2003 cited by 353

  18. Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes

    Authors: , , , , , , , - Diabetes Care 2005 cited by 311

  19. Low Fasting Plasma Glucose Level as a Predictor of Cardiovascular Disease and All-Cause Mortality

    Authors: , , , , , - Circulation 2000 cited by 142

  20. Mode of Onset of Type 2 Diabetes from Normal or Impaired Glucose Tolerance

    Authors: , , , , , - Diabetes 2004 cited by 153

  21. National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study

    Authors: , , , , - Circulation 2004 cited by 662

  22. Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 1995 cited by 596

  23. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2

    Authors: , , , , , , , , - Nature Genetics 1997 cited by 439

  24. Linkage of Type 2 Diabetes Mellitus and of Age at Onset to a Genetic Location on Chromosome 10q in Mexican Americans

    Authors: , , , , , , , - The American Journal of Human Genetics 1999 cited by 345